By InvitationNot Applicable

Little NIRVANA for Pediatric Pain and Anxiety

United States130 participantsStarted 2025-11-15

Plain-language summary

The aim of this study is to test the feasibility of using Little NIRVANA (augmented reality (AR)) for managing anxiety and pain for children 2-8 years old during hospital emergency peripheral intravenous (PIV) insertions. The investigators hypothesize that Little NIRVANA plus a numbing cream will reduce pain and anxiety for patients undergoing PIV placement in the emergency department (ED) when compared to the cream alone. It is anticipated that using the Little NIRVANA will not increase the ED length of stay, failed PIV placement attempts, or the need for additional intervention.

Who can participate

Age range2 Years – 8 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients undergoing PIV line placement (peripheral IV order placed while patient is in the ED); * Patients 2-8 years of age (inclusive) Exclusion Criteria: * Non-English speaking (Little NIRVANA is currently only available in English and Dutch); * those for whom utilizing AR is deemed not feasible by the attending ED physician (e.g., critical illness)

What they're measuring

Proxy reported pain

Timeframe: Immediately following the PIV line placement

Proxy reported anxiety

Timeframe: Immediately following the PIV line placement

Trial details

NCT IDNCT06795126

SponsorNationwide Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-30

View on ClinicalTrials.gov More Acute Pain trials